We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Quest Diagnostics
DGX
$26.3B
| $12M | 0.02% |
100,851
-27,351
| -21% | -$3.33M |
|
402
EPAM Systems
EPAM
$4.86B
| $12M | 0.02% |
33,531
-273
| -0.8% | -$91.1K |
|
403
PVH
PVH
$3.99B
| $12M | 0.02% |
127,291
+126,733
| +22,712% | +$9.65M |
|
404
DaVita
DVA
$11.5B
| $11.9M | 0.02% |
101,024
-176
| -0.2% | -$17.9K |
|
405
Texas Roadhouse
TXRH
$13.7B
| $11.8M | 0.01% |
151,342
+149,984
| +11,044% | +$11.2M |
|
406
SBA Communications
SBAC
$19.4B
| $11.7M | 0.01% |
41,630
+757
| +2% | +$222K |
|
407
Zoom
ZM
$29.7B
| $11.7M | 0.01% |
34,798
+23,080
| +197% | +$10.3M |
|
408
RPM International
RPM
$14.8B
| $11.6M | 0.01% |
128,151
+58,085
| +83% | +$5.12M |
|
409
Primerica
PRI
$10.2B
| $11.6M | 0.01% |
86,263
-20,423
| -19% | -$2.57M |
|
410
HNI Corp
HNI
$3.53B
| $11.5M | 0.01% |
+335,112
| New | +$12M |
|
411
Graphic Packaging
GPK
$3.51B
| $11.5M | 0.01% |
678,183
-42,164
| -6% | -$638K |
|
412
Pool Corp
POOL
$7.31B
| $11.3M | 0.01% |
30,469
-51,415
| -63% | -$17.9M |
|
413
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
| $11M | 0.01% |
206,543
+100,496
| +95% | +$4.98M |
|
414
Flowers Foods
FLO
$1.53B
| $10.9M | 0.01% |
483,727
-5,668
| -1% | -$132K |
|
415
IBM
IBM
$220B
| $10.9M | 0.01% |
90,457
-2,277
| -2% | -$263K |
|
416
Darden Restaurants
DRI
$24.1B
| $10.9M | 0.01% |
91,150
+30,443
| +50% | +$3.26M |
|
417
Verisk Analytics
VRSK
$24.7B
| $10.8M | 0.01% |
52,083
+909
| +2% | +$177K |
|
418
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
| – | – |
0
| – | – |
|
419
Campbell Soup
CPB
$6.73B
| $10.5M | 0.01% |
217,898
-448,366
| -67% | -$21.7M |
|
420
Gilead Sciences
GILD
$162B
| $10.4M | 0.01% |
179,095
-111,173
| -38% | -$6.71M |
|
421
Truist Financial
TFC
$64.2B
| $10.4M | 0.01% |
217,625
-2,655
| -1% | -$120K |
|
422
Trane Technologies
TT
$105B
| $10.3M | 0.01% |
71,184
+64,280
| +931% | +$8.88M |
|
|
DEA
423
Easterly Government Properties
DEA
$1.18B
| $10.3M | 0.01% |
181,776
+1,940
| +1% | +$107K |
|
424
Aflac
AFL
$64.5B
| $10.2M | 0.01% |
230,418
+218,128
| +1,775% | +$8.93M |
|
|
CTRA
425
DELISTED
Coterra Energy
CTRA
| $10.2M | 0.01% |
628,310
+620,836
| +8,307% | +$10.9M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.